PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportsiron-deficiency anemia
MeSH D018798 - iron-deficiency anemia
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D000090463:Iron deficiencies
0 Companies
0 Drugs
Success rate
D000747:Hypochromic anemia
0 Companies
0 Drugs
Success rate
D018798: 
Iron-deficiency anemia
5 Companies
3 Drugs
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Covis PharmaFerumoxytol Feraheme 2023-06-30 2009-06-30   
NorgineFerric maltol Feraccru  2016-02-18   
PharmacosmosFerric derisomaltose Monoferric 2029-03-25 2020-01-16   
SandozFerumoxytol Ferumoxytol  2021-01-15   
TakedaFerumoxytol Rienso  2012-06-15   
Clinical Trials
Historical Success Rate
Phase 1
73%
11/15
Phase 2
90%
9/10
Phase 3
73%
11/15
Approved: 3Overall Success rate: 48%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Norgine
Ferric maltol
Pharmacosmos
Ferric derisomaltose,
Iron sucrose,
Antithrombin iii,
Ademetionine,
Sodium ascorbate,
Sodium chloride,
Retinol,
Natrium,
Ferinject,
Arm1,
Pcv,
Arm2,
Bolus
Sandoz
Ferinject
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use